Cited by

• Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia.

  Nicod P, Biollaz J, Waeber B, Goy JJ, Polikar R, Schlapfer J, Schaller MD, Turini GA, Nussberger J, Hofbauer KG, et al. Nicod P, et al. Br Heart J. 1986 Nov;56(5):433-9. doi: 10.1136/hrt.56.5.433. Br Heart J. 1986. PMID: 3790379 Free PMC article.
• Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure.

  Wehrens XH, Lehnart SE, Reiken S, van der Nagel R, Morales R, Sun J, Cheng Z, Deng SX, de Windt LJ, Landry DW, Marks AR. Wehrens XH, et al. Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9607-12. doi: 10.1073/pnas.0500353102. Epub 2005 Jun 22. Proc Natl Acad Sci U S A. 2005. PMID: 15972811 Free PMC article.
• The Influence of the Sympathetic Nervous System on Cardiometabolic Health in Response to Weight Gain or Weight Loss.

  Lambert GW, Patel M, Lambert EA. Lambert GW, et al. Metabolites. 2025 Apr 23;15(5):286. doi: 10.3390/metabo15050286. Metabolites. 2025. PMID: 40422864 Free PMC article. Review.
• Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.

  Ricci S, Zaniol P, Teglio V, Baraldi P, Mattioli G. Ricci S, et al. Br J Clin Pharmacol. 1982;14 Suppl 2(Suppl 2):209S-215S. doi: 10.1111/j.1365-2125.1982.tb02079.x. Br J Clin Pharmacol. 1982. PMID: 6291564 Free PMC article.
• Activation of the neuroendocrine response in heart failure: adaptive or maladaptive process?

  Ferrari R, Ceconi C, Curello S, Ferrari F, Confortini R, Pepi P, Visioli O. Ferrari R, et al. Cardiovasc Drugs Ther. 1996 Nov;10 Suppl 2:623-9. doi: 10.1007/BF00052509. Cardiovasc Drugs Ther. 1996. PMID: 9115956 Review.